Projects

  • CXCR4 antagonists in acute lymphoblastic leukemia.
  • Enhancement of the effects of cytotoxic agents by mTOR inhibitors in acute lymphoblastic leukemia.
  • Antagonists of p38 MAPK as therapeutics for acute lymphoblastic leukemia.
  • CXCR4 in ALL cell trafficking and chemo-sensitivity.
  • The role of S1P in HSC trafficking.